Published in Cancer Weekly, November 25th, 1996
The collaborative clinical trials agreement, established in 1995 between the two organizations and Bristol-Myers Squibb Co., was designed to study the anticancer effects of thalidomide in breast, prostate, and brain cancer, as well as Kaposi's sarcoma (KS).
The brain cancer trials began in March 1996 at the Dana-Farber Cancer Institute, Boston, Massachusetts, M.D. Anderson Cancer Center, Houston, Texas,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.